|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
10,820,000 |
Market
Cap: |
1.30(B) |
Last
Volume: |
401,241 |
Avg
Vol: |
400,142 |
52
Week Range: |
$115.55 - $119.99 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Heska sells veterinary and animal health diagnostic and specialty products. Co.'s primary focus is on the canine and feline healthcare space. Co.'s business is composed of two segments: North America and International. Co.'s main product categories sold in both segments include: Point of Care laboratory instruments and consumables; digital imaging diagnostic instruments, software and services; digital cytology services; local and cloud-based data services; allergy testing and immunotherapy; and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
14,458 |
Total Buy Value |
$0 |
$0 |
$0 |
$851,078 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
2 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Wrenn Carol |
Director |
|
2018-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
705 |
5,249 |
|
- |
|
Humphrey Scott |
Director |
|
2018-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
705 |
1,272 |
|
- |
|
Sveen David E. |
Director |
|
2018-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
705 |
8,473 |
|
- |
|
Trowbridge Bonnie J. |
Director |
|
2018-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
705 |
1,249 |
|
- |
|
Riley Sharon L. |
Director |
|
2018-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
705 |
3,999 |
|
- |
|
Gordon G Irwin |
Director |
|
2018-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
705 |
33,606 |
|
- |
|
Mcginley Michael J |
Presi, Biologic. & Pharm. |
|
2018-03-17 |
4 |
D |
$78.50 |
$446,273 |
D/D |
(5,685) |
86,776 |
|
- |
|
Lippincott Rod |
EVP, Comp. Animal Health Sales |
|
2018-03-17 |
4 |
D |
$78.50 |
$151,427 |
D/D |
(1,929) |
8,316 |
|
- |
|
Wisnewski Nancy |
EVP, Diag. Ops & Prod. Dev. |
|
2018-03-17 |
4 |
D |
$78.50 |
$250,023 |
D/D |
(3,185) |
40,358 |
|
- |
|
Eyl Steven M. |
EVP, Global Sales & Marketing |
|
2018-03-17 |
4 |
D |
$78.50 |
$126,150 |
D/D |
(1,607) |
10,288 |
|
- |
|
Asakowicz Steve |
EVP, Comp. Animal Health Sales |
|
2018-03-17 |
4 |
D |
$78.50 |
$151,348 |
D/D |
(1,928) |
8,276 |
|
- |
|
Napolitano Jason A |
COO, Chief Strategist and Sec. |
|
2017-12-28 |
4 |
D |
$81.23 |
$419,066 |
D/D |
(5,159) |
37,960 |
|
- |
|
Napolitano Jason A |
COO, Chief Strategist and Sec. |
|
2017-12-28 |
4 |
OE |
$18.30 |
$201,300 |
D/D |
11,000 |
43,119 |
|
- |
|
Wisnewski Nancy |
EVP, Diag. Ops & Prod. Dev. |
|
2017-12-13 |
4 |
D |
$80.09 |
$128,064 |
D/D |
(1,599) |
43,529 |
|
- |
|
Wisnewski Nancy |
EVP, Diag. Ops & Prod. Dev. |
|
2017-12-13 |
4 |
OE |
$18.30 |
$128,100 |
D/D |
7,000 |
45,128 |
|
- |
|
Mcginley Michael J |
Presi, Biologic. & Pharm. |
|
2017-11-30 |
4 |
S |
$86.02 |
$559,124 |
D/D |
(6,500) |
92,446 |
|
- |
|
Mcginley Michael J |
Presi, Biologic. & Pharm. |
|
2017-11-29 |
4 |
S |
$87.02 |
$611,282 |
D/D |
(7,025) |
98,946 |
|
- |
|
Mcginley Michael J |
Presi, Biologic. & Pharm. |
|
2017-11-28 |
4 |
S |
$88.19 |
$70,549 |
D/D |
(800) |
105,971 |
|
- |
|
Mcginley Michael J |
Presi, Biologic. & Pharm. |
|
2017-11-27 |
4 |
S |
$88.54 |
$89 |
D/D |
(1) |
106,771 |
|
- |
|
Wisnewski Nancy |
EVP, Diag. Ops & Prod. Dev. |
|
2017-08-31 |
4 |
S |
$102.21 |
$84,327 |
D/D |
(825) |
38,114 |
|
- |
|
Mcmahon John |
VP, Chief Financial Officer |
|
2017-08-30 |
4 |
S |
$100.60 |
$263,857 |
D/D |
(2,608) |
68 |
|
- |
|
Mcmahon John |
VP, Chief Financial Officer |
|
2017-08-30 |
4 |
OE |
$28.39 |
$165,144 |
D/D |
2,608 |
2,676 |
|
- |
|
Humphrey Scott |
Director |
|
2017-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
567 |
567 |
|
- |
|
Asakowicz Steve |
EVP, Comp. Animal Health Sales |
|
2017-06-01 |
4 |
S |
$100.00 |
$38,231 |
D/D |
(382) |
10,000 |
|
- |
|
Asakowicz Steve |
EVP, Comp. Animal Health Sales |
|
2017-06-01 |
4 |
OE |
$18.13 |
$6,926 |
D/D |
382 |
10,382 |
|
- |
|
465 Records found
|
|
Page 11 of 19 |
|
|